Announcements Trials
Browse Landscape

Status

Completed 7Active not recruiting 7Recruiting 4Unknown 3Terminated 2Not yet recruiting 2Withdrawn 1Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Hyperlipidemias 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Pemetrexed 2trilaciclib 1trastuzumab deruxtecan 1pembrolizumab 1lorlatinib 1aumolertinib 1Gemcitabine 1Cisplatin 1Carboplatin 1Anterior Temporal Lobectomy 1Afatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Enrolling by invitation × Carcinoma, Non-Small-Cell Lung × lorlatinib × Clear all
NCT06876675 2025-03-14

LORLATINIB-related HYPERLIPIDEMIA in ALK+ Non-Small Cell Lung Cancer

Peking University Third Hospital

Enrolling by invitation
167 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Hyperlipidemias

Data powered by HemOnc (CC BY 4.0) Colophon âš¡